Munich Re is rewriting the terms of its own risk appetite. In a deliberate pivot away from external protection, the German reinsurance giant will slash its retrocession programme to $600 million for 2026 — down from $1.55 billion a year earlier — and dismantle two of its sidecar vehicles, Eden Re and Leo Re. The move marks a clear departure from the model of offloading risk to capital markets in favour of retaining more underwriting margin in-house.
The strategy carries a double-edged logic. By buying less reinsurance from third parties and investors, the group keeps more premium income on its own books. That could lift profitability in benign years. It also exposes the balance sheet more directly to major catastrophe events — a trade-off the market is likely to price into the stock faster when losses spike.
That sensitivity is already showing. Munich Re’s shares are trading around €487-488, down roughly 11% year-to-date and sitting 9% below their 200-day moving average. On a monthly basis the stock has shed more than 14%. The technical picture remains bruised, even as short sellers have been unwinding their bearish bets in recent weeks.
None of this is a reflection of weak operational performance. In the first quarter of 2026, net profit reached €1.7 billion and the combined technical result surged to nearly €2.7 billion, supported by an unusually low large-loss burden. The underlying underwriting discipline that produced a record net profit of €6.1 billion in the full year 2025 is very much intact. Management has reaffirmed its 2026 target of €6.3 billion.
Top-line growth is another story. Insurance revenue slipped to just over €15 billion in Q1, compared with €15.8 billion a year earlier. A strengthening euro is the culprit: premiums earned in dollars are worth less when translated back. That headwind has forced Munich Re to prioritise margin over volume.
Should investors sell immediately? Or is it worth buying Münchener Rück?
The same logic played out in the April renewal season. Munich Re systematically walked away from contracts that failed to meet its return thresholds, allowing written premium to shrink by almost 19% to €2 billion. In the broader January renewal round, volumes fell 7.8% to €13.7 billion while prices softened by a moderate 2.5%. The message from the boardroom is consistent: stable margins beat market share when the pricing cycle is no longer running hot.
Capital remains abundant even after factoring in a planned €2.25 billion share buyback. The solvency ratio stands at 292%, well above regulatory minimums. That strong capital base is precisely what enables the shift toward retaining more risk — Munich Re is effectively betting that its own underwriting discipline can outperform the cost of external cover.
Away from the numbers, the company is making a governance change. KPMG will take over as auditor from EY, a decision by the supervisory board linked to the fallout from the Wirecard scandal. The audit oversight body APAS had previously imposed a ban on EY from taking on new audit mandates.
Analyst views on Munich Re remain split between buy and neutral ratings. The next concrete test for the stock will be the July renewal round: if pricing holds steady, the pressure on the equity could ease. If the euro stays strong and volumes keep shrinking, the drag will persist. For now, the group is making a clear strategic wager — that its own balance sheet is a better engine for profit than anyone else’s.
Ad
Münchener Rück Stock: Buy or Sell?! New Münchener Rück Analysis from May 21 delivers the answer:
The latest Münchener Rück figures speak for themselves: Urgent action needed for Münchener Rück investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from May 21.
Münchener Rück: Buy or sell? Read more here...
